Variantyx Combines Long and Short Reads for Rare Disease Whole-Genome Diagnostic Test

• By Variantyx
• Posted in General Company Updates

GenomeWeb recently wrote a profile on Genomic Unity 2.0® – the first commercially available test to incorporate third-generation long-read Oxford Nanopore sequencing alongside short-read sequencing in a clinical diagnostic context:

“Genetic testing firm Variantyx has launched a rare disease diagnostic test that combines short- and long-read whole-genome sequencing and promises to deliver more comprehensive variant analysis to help improve diagnostic yield.”

Read the full article